Corvus Energy, Bergen, Norway, recently announced that it has received type approval from Lloyd’s Register (LR) for its ...

Dominic Norton discusses focusing on the shift to digital vulnerabilities, including securing IoT devices in the public ...

The State CET Cell, Maharashtra, has extended the MAH CET 2025 registration deadline for MBA, MCA, BBA, BCA, BBM, and BMS ...

We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Substack by Magnus Ofstad. In this article, we will ...

Chimeric antigen receptor T-cell (CAR-T) therapeutics have emerged as a dominating cancer treatment within cell and gene ...

Fluid handling technology provider Monitor Pumps & Systems’ pumps are not only suited to water-related applications but also ...

The European Commission (EC) has granted approval to Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other Friday’s worst performing stocks. Wall Street’s main indices bounced back on Friday, ...

Opdualag – which combines the PD-1 inhibitor nivolumab in BMS' blockbuster cancer drug Opdivo with LAG-3 inhibitor relatlimab – was unable to improve on Opdivo alone in the RELATIVITY-098 ...

The decision to go all-in on the programme comes two years after BMS paid $80 million to take exclusive, worldwide opt-in rights to PRX005, and means that the big pharma will now be responsible ...

In the immediate wake of his team’s 69-62 triumph against Rice in the American Athletic Conference Tournament final, USF coach Jose Fernandez suggested the Bulls could lurk as a dangerous double ...

Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced the appointment of Todd F. Baumgartner, MD, MPH ...